2019
DOI: 10.21608/omx.2019.15575.1035
|View full text |Cite
|
Sign up to set email alerts
|

Versatility of Injectable Platelet Rich Fibrin versus autologous blood injection in the Treatment of Chronic Recurrent Temporomandibular Joint Dislocation

Abstract: The aim of this study was to investigate the effect of injectable PRF ( i-PRF) versus the autologous blood injection (ABI) in management of chronic recurrent temporomandibular joint (TMJ) dislocation. Patients and Methods: Thirty patients were participated in this study. They were randomly assigned to equalsized groups (group I injected by autologous blood while group II injected by i-PRF). MRIs of the patients were taken preoperatively, one, and three month after the injection. Also, a verbal scale expressing… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(7 citation statements)
references
References 16 publications
0
7
0
Order By: Relevance
“…The awareness of PRF therapy for joint diseases is high amongst the participants of the present study. PRF, especially the I-PRF has found great significance in the treatment of osteoarthritis, TMJ internal derangement, and other degenerative temporomandibular joint diseases [32,33].…”
Section: Discussionmentioning
confidence: 99%
“…The awareness of PRF therapy for joint diseases is high amongst the participants of the present study. PRF, especially the I-PRF has found great significance in the treatment of osteoarthritis, TMJ internal derangement, and other degenerative temporomandibular joint diseases [32,33].…”
Section: Discussionmentioning
confidence: 99%
“…Items that were in dispute were moved to the full-text analysis stage in order to reach an agreement. At the stage of full-text eligibility, four studies were rejected in accordance with the above PICO criteria [48][49][50][51]. The detailed reasons for these decisions are presented in Table 4.…”
Section: Study Selectionmentioning
confidence: 99%
“…The overall small number of studies considering intracavitary administration of I-PRF as part of TMD therapy makes it difficult to assess the efficiency of this preparation [26,48,49,[52][53][54][55][56][57][58]. The few studies comparing arthrocentesis and I-PRF with any other injection therapy were included in the quantitative section of this systematic review [53][54][55].…”
Section: Limitations Of the Evidencementioning
confidence: 99%
See 2 more Smart Citations